Efectos adversos del tratamiento farmacológico del tabaquismo

268
Efectos adversos del tratamiento farmacológico del tabaquismo
60. Olson K, Cadario B. Bupropion, seizures, and the pharmacist’s role. Can Pharm J
1999; 132: 25-6.
61. Medicines Control Agency. Zyban (bupropion hydroochloride) safety update. 31
March 2001. http://www.mca.gov.uk (Consulta 6/4/02).
62. Committee for Proprietary Medicinal Products Meeting of 23 to 25 July 2002. European
Agency for the Evaluation of Medicinal Products.
http://www.emea.eu.int/htms/hotpress/h367702.htm (Consulta 7/8/02).
63. Bupropion hydrochloride. En: AHFS Drug Information 2002. Bethesda, MD: American
Society of Health-System Pharmacists; 2002. p. 2212-22.
64. Pollock BG, Sweet RA, Kirshner M, Reynolds III CF. Bupropion plasma levels and
CYP2D6. Ther Drug Monit 1996; 18: 581-5.
65. Hesse LM, Venkatakrishnan K, Court MH, von Moltke LL, Duan SX, Shader RI et al.
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions
with other antidepressants. Drug Metab Dispos 2000; 28: 1176-83.
66. Jefferson JW. Drug interactions- friend or foe? J Clin Psychiatry 1998; 59 (Suppl
4): 37-47.
67. Ketter TA, Jenkins JB, Schroeder DH, Pazzaglia PJ, Marangell LB, George MS et al.
Carbamazepine but not valproate induces bupropion metabolism. J Clin Psychopharmacol
1995; 15: 327-33.
68. Kustra R, Corrigan B, Dunn J, Duncan B, Hsyu PH. Lack of effect of cimetidine on
the pharmacokinetics of sustained-release bupropion. J Clin Pharmacol 1999; 39:
1184-8.
69. Preskorn SH. Should bupropion dosage be adjusted based upon therapeutic drug
monitoring? Psychopharmacol Bull 1991; 27: 637-43.
70. Shad MU, Preskorn SH. A possible bupropion and imipramine interaction. J Clin
Psychopharmacol 1997; 17: 118-9.
71. Weintraub D. Nortriptyline toxicity secondary to interaction with bupropion sustained-release.
Depress Anxiety 2001; 13: 50-2.
72. Goetz CG, Tanner CM, Klawans HL. Bupropion in Parkinson’s disease. Neurology
1984; 34: 1092-4.
73. Elko CJ, Burgess JL, Robertson WO. Zolpidem-associated hallucinations and serotonin
reuptake inhibition: a possible interaction. J Toxicol Clin Toxicol 1998; 36:
195-203.
74. Bupropion. En: Briggs GG, Freeman, RK, Yaffe SJ (eds.). Drugs in pregnancy and lactation.
6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2002. p. 155-7b.
75. Perruchoud AP, Krause H, Kläne MG, Astbury C, Hider AE, Sweet RM. Bupropion
sustained release (Zyban) is an effective and well tolerated aid to smoking cessation
in smokers with cardiovascular disease. Circulation 2001; 104 (17 suppl): II-824.
76. Van Spiegel PI, Lewis K, Seinost G, Astbury C, Hider A, Sweet R. Bupropion hydrochloride
sustained release (SR) is an effective and well tolerated aid to smoking cessation
in smokers with cardiovascular disease- a multicountry study. Eur Resp J 2001;
17 (suppl): 12S.